Topline results expected within a month and may complement positive results of a study of crofelemer for treatment of ...
The FDA grants Fast Track designation to CDI-988, an oral antiviral for the treatment and prophylaxis of norovirus infection in adult patients.
COCP READ THE FULL COCP RESEARCH REPORT Business Update Fast Track Designation for CDI-988 On April 2, 2026, Cocrystal Pharma, Inc. (NASDAQ: COCP) announced that the U.S. Food and Drug Administration ...
FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an ...
A revolutionary pancreatic cancer drug in late-stage clinical trials is extending the life of former Sen. Ben Sasse, but it is also causing painful skin side effects. Sasse, who retired from politics ...
By Dennis Thompson HealthDay ReporterTHURSDAY, April 9, 2026 (HealthDay News) — Prompt treatment with a fecal transplant can ...
CDI-988 was designed and developed as an inhibitor of a highly conserved region of noroviruses, coronaviruses, and other 3CL viral proteases. A Phase 1b norovirus challenge study is underway at Emory ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
You know the expression, “If you want to get something done, ask a working mother?” Surprising as it may seem, the same holds ...
Amazon S3 on MSN
A new COVID variant is spreading fast. Here are the signs
A highly mutated COVID variant known as “Cicada” is spreading across multiple states in the U.S., and health experts are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results